CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
基本信息
- 批准号:8136565
- 负责人:
- 金额:$ 29.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-09-01 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-hydroxybutanalAcetatesAcetoneAcidityAcidsAgeAlcoholsAldehydesAlder plantAlkenesAmidesAminesAreaAromatic AminesAziridinesBINAPBINOLBenzodiazepinesBiologicalBiological FactorsBook ChaptersBromidesCarbonCarbonatesCatalysisCharacteristicsChemicalsChemistryChromiumCobaltCollaborationsComplexCopperCoupledCrystallizationCyclizationCyclopropanesDNA Sequence RearrangementDataDetectionDevelopmentDiels Alder reactionDiscriminationDissociationDoctor of PhilosophyEffectivenessElectron TransportElectronicsEmployee StrikesEpoxy CompoundsEquilibriumEstersEthersExclusionFree EnergyFundingGoalsGrantHeterocyclic CompoundsHigh Pressure Liquid ChromatographyHydrogenHydrogen BondingHydrogen PeroxideHydrolysisHydroxide IonHydroxidesIminesIndividualInvestigationIonsIsomerismIsoquinolinesIsotopesKetonesKineticsLaboratoriesLactamsLactonesLeadLigandsLinkManganeseManuscriptsMediatingMetalsMethodologyMethodsModelingModificationNitrogenOrganic SynthesisOutcomeOxonia ActiveOxygenPalladiumPathway interactionsPhenolsPhysical condensationPolymersPositioning AttributePotassiumPreparationProceduresProcessProlinePublicationsPublishingPyrazolesPyrrolesPyrrolidinesQuinineReactionRecoveryRelative (related person)ReportingResearchResearch Peer ReviewResortRhodiumRoleRouteRutheniumScandiumSchemeSiteSolubilitySolventsSteroidsSulfonamidesSystemTemperatureThermodynamicsTitaniaTitaniumTolueneTransfer RNAUnited States National Institutes of HealthUnsaturated Fatty AcidsVariantVertebral columnWateralkyl groupanalogazetidinonebasecarbenecarbonyl compoundcarboxylatecatalystcopingcycloadditioncyclopropanedecanedeprotonationdesigndiazo compoundenolhydronium ioninhibitor/antagonistinsightinterestnoveloxidationperoxidationpi bondpreventprogramspyridinepyrrolidinepyrrolineracemizationsodium ionstereochemistrytert-Butylhydroperoxidetertiary aminetetrahydrofuranylide
项目摘要
The goal of this research program is the design and development of highly selective and efficient catalytic processes for the synthesis of biologically relevant compounds. Investigations will build upon our newest discoveries with unique catalytic uses of dirhodium carboxamidates. Breakthroughs in their applications for chemical oxidations and as chiral Lewis acids have demonstrated greatly enhanced versatility for these catalysts that will be further explored. The fixed stereodefined geometry of these catalysts provides access to highly enantioenriched products in metal carbene reactions of diazoacetates and, together with their low oxidation potentials, also provides capabilities for highly selective Lewis acid catalyzed reactions and efficient chemical oxidations. In all aims we seek high turnover numbers and high selectivities. In this funding period we will resolve limitations of chiral dirhodium carboxamidates for metal carbene transformations by novel processes for which preliminary results indicate that the aims will be achieved. We will develop diazo chemistry for catalytic stereoselective transformations to further enhance applicability of catalytic metal carbene chemistry in organic synthesis. New catalytic syntheses of multi-functional B-keto-a-
diazoesters with subsequent catalytic metal carbene transformations provides highly efficient access to more complex carbon frameworks than previously possible through reactions with diazoacetates. We will use active Lewis acidic chiral dirhodium(ll,lll) carboxamidate catalysts to broaden the range of applicable carbon-carbon bond forming transformations. Reactivity and selectivity enhancement through chiral dirhodium(ll,lll) catalysts expands their utilization to Lewis acid catalyzed reactions for which chiral dirhodium(ll,ll) catalysts are ineffective, and initial focus will be given to those transformations for which preliminary results are most
promising. We will develop and apply catalytic oxidative methodologies to compounds that are of biological significance. Newly discovered tert-butyl hydroperoxide oxidations catalyzed by dirhodium caprolactamate, based largely on its low oxidation potential and solubilities, offer a unique opportunity to develop a spectrum of oxidative transformations, compatible with water as a solvent, that are not easily achieved by other methods (especially allylic and benzylic oxidations). Applications encompass reactions with steroids, phenolic compounds, unsaturated fatty acids, amines, and other biologically relevant substrates.
该研究计划的目的是设计和开发高度选择性,高效的催化过程,以合成生物学相关化合物。调查将基于我们最新发现,并使用dirhodium羧酰胺剂的独特催化用途。在化学氧化的应用中的突破和手性刘易斯酸已经显示出这些催化剂的多功能性大大增强,将进一步探索。这些催化剂的固定立体置换几何形状可访问重生乙酸盐的金属碳烯反应中高度对映射的产物,并及其低氧化潜力,还为高度选择性的路易斯酸催化的反应和有效的化学氧化提供了能力。在所有目标中,我们都寻求高尚额的数字和高选择性。在这个资金期间,我们将通过新的过程来解决金属碳纤维转化的手性dirhodium羧酰胺剂的局限性,这些过程表明将实现目标。我们将开发重氮化学,用于催化立体选择转化,以进一步增强催化金属碳化学在有机合成中的适用性。多功能B酮-A-的新催化合成
随后的催化金属碳转化的重氮植物比以前通过与重生乙酸盐的反应相比,可以高效地进入更复杂的碳框架。我们将使用活跃的路易斯酸性手性dirhodium(LL,LLL)羧化催化剂来扩大适用的碳碳键形成变换的范围。通过手性dirhodium(LL,LLL)催化剂的反应性和选择性提高,将其利用扩大到刘易斯酸催化反应,手性dirhodium(LL,LL)催化剂无效,最初的焦点将对这些初步结果最初的焦点,以实现这些反应。
有希望的。我们将开发并应用催化氧化方法,以具有生物学意义的化合物。新发现的丁烷氢过氧化物氧化是由Dirhodium caprolactamate催化的,主要基于其低氧化潜力和溶解度,提供了一个独特的机会,可以开发出与水作为或者相兼容的氧化转化,这些氧化转化与某种方法相兼容,尤其是其他方法(尤其是其他方法)(尤其是benz yelghyalic和Benz yebyalic和Benzy)。应用包括与类固醇,酚类化合物,不饱和脂肪酸,胺和其他与生物学相关的底物的反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael PATRICK Doyle其他文献
Michael PATRICK Doyle的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael PATRICK Doyle', 18)}}的其他基金
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
2183998 - 财政年份:1991
- 资助金额:
$ 29.4万 - 项目类别:
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
2770975 - 财政年份:1991
- 资助金额:
$ 29.4万 - 项目类别:
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
6525641 - 财政年份:1991
- 资助金额:
$ 29.4万 - 项目类别:
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
3305946 - 财政年份:1991
- 资助金额:
$ 29.4万 - 项目类别:
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
6179371 - 财政年份:1991
- 资助金额:
$ 29.4万 - 项目类别:
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
6606586 - 财政年份:1991
- 资助金额:
$ 29.4万 - 项目类别:
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
6795903 - 财政年份:1991
- 资助金额:
$ 29.4万 - 项目类别:
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
7928258 - 财政年份:1991
- 资助金额:
$ 29.4万 - 项目类别:
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
7471675 - 财政年份:1991
- 资助金额:
$ 29.4万 - 项目类别:
相似国自然基金
微囊泡介导肺泡上皮祖细胞醋酸盐代谢重编程向AT2细胞分化促进ARDS炎症修复的作用机制
- 批准号:82360020
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
肝癌微环境富集醋酸盐增强内皮细胞乙酰化修饰并促进血管生成
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
肝癌微环境富集醋酸盐增强内皮细胞乙酰化修饰并促进血管生成
- 批准号:82273313
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
络合萃取法提取生物油酚类化合物的效能及机理研究
- 批准号:21206142
- 批准年份:2012
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Microparticle resiquimod for the treatment of visceral leishmaniasis
瑞西莫德微粒治疗内脏利什曼病
- 批准号:
9259909 - 财政年份:2016
- 资助金额:
$ 29.4万 - 项目类别:
Identification of Tumor Promotion Susceptibility Genes
促癌易感基因的鉴定
- 批准号:
8367236 - 财政年份:2008
- 资助金额:
$ 29.4万 - 项目类别: